Legal & General Group Plc Cuts Stock Holdings in Enhabit, Inc. (NYSE:EHAB)

Legal & General Group Plc lessened its stake in Enhabit, Inc. (NYSE:EHAB - Free Report) by 90.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,460 shares of the company's stock after selling 41,641 shares during the quarter. Legal & General Group Plc's holdings in Enhabit were worth $35,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Paradice Investment Management LLC boosted its holdings in Enhabit by 12.8% in the fourth quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock valued at $13,903,000 after acquiring an additional 201,997 shares during the last quarter. JPMorgan Chase & Co. increased its position in Enhabit by 37.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company's stock worth $2,411,000 after purchasing an additional 83,707 shares in the last quarter. ExodusPoint Capital Management LP acquired a new stake in Enhabit during the 4th quarter worth approximately $593,000. Fox Run Management L.L.C. lifted its position in Enhabit by 290.2% during the fourth quarter. Fox Run Management L.L.C. now owns 42,237 shares of the company's stock valued at $330,000 after buying an additional 31,412 shares in the last quarter. Finally, Magnetar Financial LLC purchased a new stake in Enhabit during the fourth quarter worth approximately $171,000.

Enhabit Price Performance

EHAB opened at $7.87 on Friday. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $10.70. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a market cap of $397.03 million, a price-to-earnings ratio of -3.39 and a beta of 1.60. The company has a fifty day simple moving average of $8.28 and a 200 day simple moving average of $8.02.

Analysts Set New Price Targets

Separately, Jefferies Financial Group restated a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.